We are live on ! Find out more
SIOX

Sio Gene Therapies Inc. Common Stock
SIOX

Delisted

SIOX was delisted on the 22nd of March, 2023.

Back to rankings

71 hedge funds and large institutions have $1.29B invested in Sio Gene Therapies Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 16 increasing their positions, 7 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

148% more call options, than puts

Call options by funds: $3.08M | Put options by funds: $1.24M

129% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 7

100% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 19

37% more funds holding

Funds holding: 52 → 71 (+19)

35% less capital invested

Capital invested by funds: $1.99B → $1.29B (-$696M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
71
Holders Change
+19
Holders Change %
+36.54%
% of All Funds
1.98%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
38
Increased
16
Reduced
7
Closed
19
Calls
$3.08M
Puts
$1.24M
Net Calls
+$1.84M
Net Calls Change
+$1.63M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.5M
2
JHIU
Janus Henderson Investors US
Colorado
+$16.7M
3
DM
Deerfield Management
New York
+$7.1M
4
Blackstone Inc
Blackstone Inc
New York
+$5.18M
5
BFA
BlackRock Fund Advisors
California
+$4.95M

Top Sellers

Rank Fund Capital Flow
1
AWG
Alpha Wave Global
New York
-$20.4M
2
PHS
PFM Health Sciences
California
-$19.4M
3
LCP
Lamond Capital Partners
California
-$14.1M
4
Franklin Resources
Franklin Resources
California
-$4.62M
5
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$3.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACP
26
Acuta Capital Partners
California
$1.81M -$440K -3,750 -18%
Alyeska Investment Group
27
Alyeska Investment Group
Illinois
$1.47M -$165K -1,405 -9%
BIT
28
BlackRock Institutional Trust
California
$1.35M +$1.53M +13,080 New
Lazard Asset Management
29
Lazard Asset Management
New York
$1.32M -$30.4K -259 -2%
State of New Jersey Common Pension Fund D
30
State of New Jersey Common Pension Fund D
New Jersey
$1.1M +$1.25M +10,625 New
ACM
31
Atika Capital Management
New York
$969K – – –
FCMI
32
Foresite Capital Management II
California
$840K – – –
BIM
33
BlackRock Investment Management
Delaware
$792K +$679K +5,788 +309%
Point72 Asset Management
34
Point72 Asset Management
Connecticut
$713K +$809K +6,900 New
NSEDCP
35
NJ State Employees Deferred Compensation Plan
New Jersey
$659K +$748K +6,375 New
TCIM
36
TIAA CREF Investment Management
New York
$545K +$619K +5,277 New
BlackRock
37
BlackRock
New York
$528K – – –
Vanguard Group
38
Vanguard Group
Pennsylvania
$485K +$551K +4,695 New
CS
39
Credit Suisse
Switzerland
$477K +$541K +4,615 New
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$445K +$505K +4,305 New
Citadel Advisors
41
Citadel Advisors
Florida
$435K -$2.81K -24 -0.6%
OPPM
42
Opus Point Partners Management
New York
$397K +$450K +3,840 New
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$333K +$378K +3,225 New
SM
44
Sabby Management
Florida
$272K +$309K +2,632 New
BCM
45
Bourgeon Capital Management
Connecticut
$258K +$293K +2,500 New
Bank of New York Mellon
46
Bank of New York Mellon
New York
$242K +$274K +2,335 New
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$222K +$244K +2,085 +3,310%
TA
48
Teachers Advisors
New York
$185K +$210K +1,794 New
Geode Capital Management
49
Geode Capital Management
Massachusetts
$173K +$197K +1,682 New
Northern Trust
50
Northern Trust
Illinois
$160K +$181K +1,544 New
1
2
3 4

SIOX Hedge Fund Activity: Q3 2015 in Review

71 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Sio Gene Therapies Inc. Common Stock (SIOX) for Q3 2015, worth a combined $1.29B — down 35% from $1.99B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new SIOX positions and 19 closed out — a net gain of 19 holders — while 16 added to existing stakes and 7 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $18.5M. The largest seller was Alpha Wave Global, exiting entirely with an estimated $20.4M sold.

  • 71 institutional investors held Sio Gene Therapies Inc. Common Stock (SIOX) as of Q3 2015, up from 52 in Q2 2015.
  • Funds reported $1.29B of Sio Gene Therapies Inc. Common Stock stock for Q3 2015, down 35% quarter-over-quarter.
  • 38 funds opened new Sio Gene Therapies Inc. Common Stock positions in Q3 2015 and 19 closed out, a net change of +19 holders.
  • The largest Sio Gene Therapies Inc. Common Stock buyer in Q3 2015 was Fidelity Investments, an estimated $18.5M added.
  • The largest Sio Gene Therapies Inc. Common Stock seller in Q3 2015 was Alpha Wave Global, an estimated $20.4M sold.

Based on aggregated 13F filings for Q3 2015.